Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed +45.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -48.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +2250 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current ratio changed +63.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed +57.5% from the comparable as-filed period.
Operating margin changed +1285 basis points from the comparable as-filed period.
Gross margin changed +1549 basis points from the comparable as-filed period.
Trade receivables changed -12.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -18.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cost of revenue changed -43.5% from the comparable as-filed period.
Current assets changed -16.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory / revenue changed -1068 basis points from the comparable as-filed period.
Stock-based compensation changed -40.8% from the comparable as-filed period.
Inventory changed -21.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -9.2% from the comparable as-filed period.
SBC / revenue changed -196 basis points from the comparable as-filed period.
Cash & equivalents changed -10.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +14.6% from the comparable as-filed period.
Receivables / revenue changed -150 basis points from the comparable as-filed period.
R&D / revenue changed +105 basis points from the comparable as-filed period.
Research & development changed +0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.